$CAA (CalAtlantic Group, Inc.)

$CAA {{ '2016-05-06T14:34:57+0000' | timeago}} • Announcement

$CAA's net new orders for 1Q16 rose by 4% to 4,135 homes, with the dollar value of these orders up 9% and monthly sales absorption rate was 2.4 per community for 1Q16, flat from pro forma 1Q15 and up 55% from 4Q15, consistent with normal seasonal patterns. Cancellation rate was 12%, down 200 basis points from 1Q15 and down from 22% for 4Q15.

$INFO {{ '2018-01-16T20:28:30+0000' | timeago}} • Infographic

$INFO IHS Markit Ltd. Earnings AlphaGraphic: Q4 2017 Highlights

$LEN {{ '2018-01-11T13:13:12+0000' | timeago}} • Infographic

$LEN $LEN.B Lennar Corporation Earnings AlphaGraphic: Q4 2017 Highlights

$LEN {{ '2018-01-11T13:04:52+0000' | timeago}} • Webcast

Following the CalAtlantic acquisition, $LEN $LEN.B said the combined company will have a top three position in 24 of the 30 largest markets in the nation with local market shares ranging from 20-40% in many markets. This local critical mass will drive huge savings, the company said.

$LEN {{ '2018-01-11T12:42:34+0000' | timeago}} • Webcast

$LEN $LEN.B said the recently passed federal tax act has added additional momentum to the economic landscape. "While many has been concerned about the effects of the new tax law on housing with its mixed bag of impacts, initial readings and reviews suggest that it is generally stimulative to the economy," the company said.

$KBH {{ '2018-01-10T21:30:35+0000' | timeago}} • Announcement

With 9% more deliveries to 3,340 homes. $KBH ended 4Q17 with a backlog value of $166Bil, up 9%. Company-wide, net orders per community for the fourth quarter averaged 3.4 per month.

$KBH {{ '2018-01-10T21:27:55+0000' | timeago}} • Announcement

With net order value growing 9% to $935.4MM, $KBH saw 4Q17 revenue surge 18% to $1.4Bil. In the quarter, the homebuilder saw net income more than double to $84.3MM or $.84 per diluted share, from last year's $37.5MM or $.40 per diluted share.

$LEN {{ '2018-01-10T11:49:36+0000' | timeago}} • Announcement

In 4Q17, $LEN said its orders were up 12% YoY to 7,357 homes, tallying to a total value of $2.8Bil. Meanwhile, backlog for the quarter of 8,935 homes, were up 17% over the same quarter last year.

$LEN {{ '2018-01-10T11:45:22+0000' | timeago}} • Announcement

$LEN's revenues from home sales grew 14% in 4Q17 to $3.3Bil, as the company delivered 5% more houses at 8% higher average sales price compared to last year.

$LEN {{ '2018-01-10T11:43:42+0000' | timeago}} • Announcement

Amidst a slow and steady housing recovery, $LEN reported 12% increase in its 4Q17 revenue to $3.79Bil, thanks to favorable interest rates and increased consumer confidence. However, net earnings witnessed a slight dip to $309.5MM, or $1.29 per share, as one of its key transactions got shifted to the upcoming quarter.

$WBA {{ '2018-01-05T17:43:00+0000' | timeago}} • Webcast

$WBA stated that its beauty differentiation stores performed stronger in 1Q18 than in prior quarters. Additionally, the company's beauty category sales in these stores continued to be markedly better than in other stores, resulting in higher retail gross margin and higher comparable retail sales.

$WBA {{ '2018-01-04T17:56:48+0000' | timeago}} • Announcement

$WBA's all three segments reported an increase in sales in 1Q18 with Retail Pharmacy USA segment's pharmacy sales, which accounts for 72.4% of the division's sales, increasing 14.1%, driven by high prescription volumes. Retail Pharmacy International's sales rose 4.1% to $3.1Bil, while Pharmaceutical Wholesale sales jumped 5.6% to $5.7Bil.

$WBA {{ '2018-01-04T17:48:01+0000' | timeago}} • Announcement

$WBA raised the lower end of its FY18 guidance by $0.05 per share and now expects adjusted diluted net EPS in the range of $5.45-5.70. This guidance does not take into account any impact from the recent U.S. tax legislation and assumes current exchange rates for the rest of the fiscal year.

$WBA {{ '2018-01-04T17:41:54+0000' | timeago}} • Announcement

Pharmacy chain $WBA posted a 22.1% slump in its 1Q18 profit, bruised by impairment of the company's equity method investment in Guangzhou Pharmaceuticals Corporation. Profit slumped to $821MM or $0.81 per share from $1.05Bil or $0.97 a year earlier. Sales, however, jumped 7.85% to $30.7Bil. On an adjusted basis, $WBA earned $1.28 per share.

$WBA {{ '2018-01-04T13:51:23+0000' | timeago}} • Infographic

$WBA Walgreens Boots Alliance, Inc. Earnings AlphaGraphic: Q1 2018 Highlights

$INFO {{ '2018-01-03T13:30:22+0000' | timeago}} • Announcement

$INFO appointed Lord Browne of Madingley and Nicoletta Giadrossi as new directors of the company. Also, Lance Uggla, the company’s president and COO, became chairman and CEO of $INFO on Jan. 1, 2018, following the retirement of chairman and CEO Jerre Stead on Dec. 31, 2017.

$RHT {{ '2017-12-20T14:24:30+0000' | timeago}} • Announcement

Open source software provider $RHT, which recently announced partnerships with $BABA and SoftBank, saw a surge in its 3Q18 profit, driven by higher subscriptions and higher revenue. Profit surged 49% to $101.3MM or $0.54 per share, up from $68MM or $0.37 a year earlier. Revenue rose 22% to $748MM. On an adjusted basis, $RHT earned $0.73 per share.

$NVR {{ '2017-12-12T22:31:34+0000' | timeago}} • Announcement

$NVR announced that its BoD has authorized the repurchase of $300MM of its outstanding common stock. The purchases will occur from time to time in the open market and/or in privately negotiated transactions as market conditions permit.

$HLS {{ '2017-12-12T13:23:46+0000' | timeago}} • Announcement

$HLS appointed Nancy Schlichting as an independent director, effective Dec. 11, 2017. With this appointment, the Board will expand to 11 directors. Schlichting currently serves on the boards of $WBA and $HRC.

$PMC {{ '2017-12-07T18:06:23+0000' | timeago}} • Announcement

$PMC announced the completion of the acquisition of PharMerica by a newly formed company controlled by KKR with an affiliate of $WBA as a minority investor.

$WBA {{ '2017-12-06T16:33:05+0000' | timeago}} • Announcement

$WBA agreed with China National Accord Medicines Corp. to become an investor in its subsidiary Sinopharm Holding Guoda Drugstores Co., which operates and franchises retail pharmacies across China. $WBA's bid met all the requirements set by the seller to buy 40% minority stake in GuoDa through a capital increase worth around $416MM.

Recent Transcripts

KBH (KB Home)
Wednesday, January 10 2018 - 10:00pm
LEN.B (Lennar Corporation)
Wednesday, January 10 2018 - 4:00pm
WBA (Walgreens Boots Alliance, Inc.)
Thursday, January 4 2018 - 1:30pm
HOV (Hovnanian Enterprises Inc.)
Thursday, December 21 2017 - 4:00pm
DHI (DR Horton Inc.)
Thursday, November 9 2017 - 1:30pm
APPS (Digital Turbine, Inc.)
Tuesday, November 7 2017 - 9:30pm
MDC (MDC Holdings Inc.)
Thursday, November 2 2017 - 4:30pm
BABA (Alibaba Group Holding Limited)
Thursday, November 2 2017 - 11:30am
FIT (Fitbit Inc.)
Wednesday, November 1 2017 - 9:00pm
HZN (Horizon Global Corporation)
Tuesday, October 31 2017 - 12:30pm
MTH (Meritage Homes Corporation)
Friday, October 27 2017 - 3:01pm
AVHI (A V Homes Inc)
Friday, October 27 2017 - 12:30pm
WBA (Walgreens Boots Alliance, Inc.)
Wednesday, October 25 2017 - 12:30pm
PHM (PulteGroup, Inc.)
Tuesday, October 24 2017 - 12:30pm
LEN.B (Lennar Corporation)
Tuesday, October 3 2017 - 3:00pm
KBH (KB Home)
Thursday, September 28 2017 - 9:00pm
INFO (IHS Markit Ltd.)
Tuesday, September 26 2017 - 12:00pm
HOV (Hovnanian Enterprises Inc.)
Thursday, September 7 2017 - 3:00pm
BABA (Alibaba Group Holding Limited)
Thursday, August 17 2017 - 11:30am
APPS (Digital Turbine, Inc.)
Monday, August 7 2017 - 8:30pm

AlphaGraphics you may like